The risk of pancreatic cancer was reduced by 34% in users of decaffeinated coffee compared with non-coffee drinkers, but this did not reach statistical significance (adjusted HR: 0.66, 95% CI: 0.43–1.01).
← all excerpts
Coffee consumption by type and risk of digestive cancer: a large prospective cohort study.
1
—
—